Sign In

Parking will be limited at the Floyd Medical Center campus, including the Emergency Care Center, due to construction and road widening. Learn more about our parking changes.

Skip Navigation LinksFloyd > Antimicrobial Stewardship > Atrium Health Floyd Cherokee Medical Center
Menu

​​​​​​Atrium Health Floyd Cherokee Medical Center Antimicrobial Stewardship

To receive medical staff credentialing credit​:​​

  1. ​Review the antimicrobial stewardship information below. ​  
  2. Fill out and submit the ​attestation form for Atrium Health Floyd​

​The Antimicrobial Stewardship program at Atrium Health Floyd Cherokee Medical Center is a coordinated effort to ensure judicious and effective use of antimicrobial therapy that includes but is not limited to the appropriate selection, dosing, route of administration and duration of antimicrobial therapy. ​Goals of the program include:

  • Streamlining therapy based on susceptibilities (de-escalation)
  • Avoiding therapeutic duplication
  • Reduction of hospital-acquired infections (Clostridium difficile)
  • Appropriate lab monitoring, renal dosing and dose optimization for the medication selected
  • Monitoring of drug-resistant pathogens based on quarterly review of antibiogram​​ and reporting   to the appropriate committees (Pharmacy and Therapeutics, AMS committee)

In addition to reporting to a multidisciplinary antimicrobial stewardship team quarterly, each patient receiving an antibiotic is reviewed by the pharmacist and nurse practitioner/physician every 24 hours.  Clinical response, pertinent labs, renal function, cultures and sensitivities are reviewed for dose optimization and de-escalation. 

Educational Resources​

Dosing Guidelines​

Future Projects​​

The following policies and procedures have been implemented at Atrium Health Floyd Cherokee Medical Center but will be reviewed and possibly revised at future antimicrobial stewardship meetings:

  • Extended Infusion Piperacillin-Tazobactam
  • Clostridium difficile updated policy
  • Once-daily Aminoglycoside dosing
  • UTI updated guidelines

Antibiotic Susceptibility Report

Program Policies​

​​​​

Return to the Attestation Form Page​